An interventional study of PS23 in Fatigue, sponsored by Chi-Chang Huang. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-12.
Sponsored by Chi-Chang Huang · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 87 studies in Fatigue with a site in Taiwan — 16 open to participants now, 19 under way, 3 of them phase 3. Fatigue · Taiwan.
Among the 87 studies in Fatigue with a site in Taiwan, this one is the 12th largest by enrollment of the 71 interventional ones that give a count, is one of 13 that started in 2022, is one of 59 with no phase, and was the 45th registered.
2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.
Browse Fatigue studies →16 of the 87 studies in Fatigue with a site in Taiwan are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in Taiwan, United States, Australia and 17 more countries
Ages 18+
Taipei City Hospital · Sites in Taiwan
Ages 18+
Alkermes, Inc. · Sites in Taiwan, United States, Australia and 12 more countries
Ages 18–70
Pfizer · Sites in Taiwan, United States, Australia and 18 more countries
Ages 18+
Chin-Wei Huang · Sites in Taiwan
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.
This study: 20 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
87 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 7 · Phase 3 6 · Phase 4 2
First in 2006; this study’s year is marked. 13 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 120 is above the median of 54 across 1,762 interventional studies indexed under Fatigue.
Median enrollment 60 across the 71 interventional studies, 120 across the 16 observational. Of the 56 that completed or were terminated, 3 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 87 have an industry lead sponsor. The 10 most frequent:
Chi-Chang Huang is the lead sponsor of 5 studies on the registry; none are open to participants now.
Chi-Chang Huang has 1 study filed under Fatigue — fewer than ten, so there is no comparison to draw.
7 of the studies in Fatigue with a site in Taiwan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT06851195Kaohsiung Medical University Chung-Ho Memorial HospitalEffect of Neuromuscular Electrical Stimulation of Lower Limbs on Improving Exercise Self-Efficacy, Dyspnea During Activity and Fatigue in Patients With Chronic Obstructive Pulmonary Disease | 2026-12-31 |
| NCT06736002Chin-Wei HuangEffects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study | 2026-12-31 |
| NCT05224518National Taiwan University Hospital Hsin-Chu BranchExercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer | 2026-12-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 87 studies in Fatigue with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise.
Studies have found that the intestinal flora of athletes is different from that of ordinary people, and short-chain fatty acids play a very important role. Previous animal experiments have found that supplementing with specific probiotics can slow down muscle loss in aging mice. In addition, clinical studies have found that supplementing with probiotics can improve sports performance by regulating the intestinal flora and related metabolites. Therefore, the purpose of this research is to explore the effects of supplementing Lactobacillus paracasei PS23 to reduce fatigue and improve physical fitness after exhaustive exercise. This study compares supplementary samples with placebo and adopts a double-blind study design.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The PS23 belongs to Lactobacillus paracasei group, 2 caps daily use.
Dietary Supplement: PS23
PS23 heat-treated, 2 caps daily use.
Dietary Supplement: PS23
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.
Dietary Supplement: PS23
PS23 belongs to Lactobacillus paracasei group.Probiotic capsules contain 10 billion CFU (colony forming units) of PS23
Stress assessment - difference of Testosterone level
To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Used commercial kit human Testosterone (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis Male 265-923 (in ng/dl) Female 15-70 (in ng/dl) for 19 years and older
Time frame: From Baseline to 6 Weeks Assessed
Difference in Clinical Biochemistry of CK level
To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Assess serum CK(Creatine Kinase, U/L) to monitor physiological fitness. Serum CK (U/L), were assessed for monitoring physiological adaptation. All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).
Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise
Difference of Muscle damage - blood level of myoglobin
To assess Muscle damage such as myoglobin (Female:14.3\~65.8, Male:17.4\~105.7) Volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human myoglobin (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise
Oxidative stress assessment - blood of MDA level
comparing blood levels of oxidative markers such as Malondialdehyde (MDA)
Time frame: From Baseline to 6 Weeks Assessed
Difference in Oxidative stress - blood level of CRP
To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, blood samples were collected with brachial venous catheters. Used commercial kit human CRP (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
Time frame: From Baseline to 6 Weeks Assessed, including baseline (0) and 3h, 24h, and 48 after exercise
The Countermovement Jump (CMJ) Test
The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The average power (MF), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.
Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.
The Countermovement Jump (CMJ) Test
The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The peak power (Fpeak), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.
Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.
The Countermovement Jump (CMJ) Test
The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. flight time (FT) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.
Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.
The Countermovement Jump (CMJ) Test
The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The strength development speed (30 ms) were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.
Time frame: From Baseline to 6 Weeks Assessed, In this study, this assessment was performed before and 24 and 48h after the exhaustive exercise program.
Wingate Anaerobic Test (WAnT)
After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The recorded results were the relative mean power (W/kg), relative peak power (W/kg), and fatigue index (%). This assessment was performed before and 24 and 72 h after the exhaustive exercise program.
Time frame: From Baseline to 6 Weeks Assessed
Isometric Mid-Thigh Pull (IMTP)
Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF), relative peak force (N/Kg), rate of force development (RFD), peak rate of force development (pRFD), time to peak force (TPF) and time to peak rate of force development (TPRFD) parameters were recorded. This assessment was performed before and 24 and 48h after the exhaustive exercise program.
Time frame: From Baseline to 6 Weeks Assessed
Isometric Mid-Thigh Pull (IMTP)
Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak force (PF) were recorded.
Time frame: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.
Isometric Mid-Thigh Pull (IMTP)
Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded.
Time frame: From Baseline to 6 Weeks Assessed. This assessment was performed before and 24 and 48h after the exhaustive exercise program.
Gut microbiota
Collect the DNA of fecal flora to test the diversity and abundance of gut microbiota in Stool samples before and after probiotics
Time frame: From Baseline to 6 Weeks Assessed
Change in Perceived Stress Scale (PSS) Score From Baseline to Change in Perceived Stress Scale (PSS)
The PSS scores is a rating tool used to gauge the course of stree. The minimum total score possible is 0 and the maximum total score possible is 40. Higher values represent a worse outcome.
Time frame: From Baseline to 6 Weeks Assessed
Differences in the The Profile of Mood States (POMS) before and after probiotics consumption
The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. The Chinese version POMS measures six different dimensions of mood swings over a period of time. These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment. A four-point scale ranging from "not at all" to "extremely" is administered by experimenters to patients to assess their mood states.
Time frame: From Baseline to 6 Weeks Assessed
The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16, QLESQ-16
The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16 (QLESQ-16) is a valid, reliable self-report instrument for assessing quality of life.
Time frame: From Baseline to 6 Weeks Assessed
Visual Analogue Scale-GI (VAS-GI)
Visual Analogue Scale (VAS) consists of a line, 10 cm in length. Individuals point to or mark a spot on the line where they feel indicates their current their emotion, fatigue level and sleep quality. The score of emotion level is from 0cm (very nervous) to 10 cm (very relaxing). The score of fatigue level is from 0 cm (very energetic) to 10 cm (very sleepy). The score of sleep quality is from 0 cm (poor) to 10 cm (sleep well). The maximum total score is 100% (equal 10cm).
Time frame: From Baseline to 6 Weeks Assessed
Change in Patient Global Impression of Change (PGIC)
The PGIC consists of one item taken from the clinical global impression and adapted to the patient. The minimum total score possible is 1 and the maximum total score possible is 7. Higher values represent a worse outcome.
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - AST
Safety is assessed function of liver and kidney such as AST (8-38 IU/L).
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - ALT
Safety is assessed function of liver and kidney such as ALT (4-44 IU/L).
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - T-Cholesterol
Safety is assessed function of liver and kidney such as T-Cholesterol (\<170 mg/dL).
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - Uric Acid
Safety is assessed function of liver and kidney such as Uric Acid (3.4-7.6 mg/dl)
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - Bun
Safety is assessed function of liver and kidney such as Bun (6-20 mg/dl)
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - Creatinine
Safety is assessed function of liver and kidney such as Creatinine (0.6-1.3 mg/dl)
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - Glucose
Safety is assessed function of liver and kidney such as Glucose (70\~100 mg/dL)
Time frame: From one week before Baseline to 6 Weeks Assessed
Safety assessment - Triglycerides
Safety is assessed function of liver and kidney such as Triglycerides (\<150 mg/dL)
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - LDL
Safety is assessed function of liver and kidney such as LDL (0\~140mg/dl)
Time frame: From Baseline to 6 Weeks Assessed
Safety assessment - HDL
Safety is assessed function of liver and kidney such as HDL (\>40mg/dl)
Time frame: From Baseline to 6 Weeks Assessed
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from May 2022 to primary completion in Jul 2022, 2 months.
Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 2 months is below that.
Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: PS23
Chi-Chang Huang